無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

合成幹細胞の世界市場 (〜2028年):心血管疾患・神経系疾患・その他 (癌・糖尿病・消化器疾患・筋骨格障害)

Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America, Europe, APAC, RoW) - Global Forecast to 2028

発行 MarketsandMarkets 商品コード 755492
出版日 ページ情報 英文 55 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.75円で換算しております。
Back to Top
合成幹細胞の世界市場 (〜2028年):心血管疾患・神経系疾患・その他 (癌・糖尿病・消化器疾患・筋骨格障害) Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America, Europe, APAC, RoW) - Global Forecast to 2028
出版日: 2018年12月05日 ページ情報: 英文 55 Pages
概要

世界の合成幹細胞の市場は予測期間中22.5%のCAGR (年間複合成長率) で推移し、2023年の1350万米ドルから、2028年には3720万米ドルの規模に成長すると予測されています。胚性幹細胞に関する倫理上の懸念、腫瘍形成や天然幹細胞の免疫による拒絶反応のリスクなどの要因が同市場の成長を推進しています。しかし一方で、不明確で体系化されていない合成幹細胞の利用に関する法規制が同市場のさらなる成長の障壁となっています。

当レポートでは、世界の合成幹細胞の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、用途・地域別の動向と市場規模の推移と予測、主要大学のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題
  • 市場影響分析

第6章 合成幹細胞市場の分析・予測:用途別

  • イントロダクション
  • 心血管疾患
  • 神経系疾患
  • その他

第7章 合成幹細胞市場の分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 大学プロファイル

  • NORTH CAROLINA STATE UNIVERSITY
  • ZHENGZHOU UNIVERSITY

第9章 付録

図表

LIST OF TABLES

  • TABLE 1: APPLICATIONS: CLINICAL TRIALS
  • TABLE 2: SYNTHETIC STEM CELLS MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • TABLE 3: SYNTHETIC STEM CELLS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • TABLE 4: NORTH AMERICA: SYNTHETIC STEM CELLS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARIES
  • FIGURE 4: MARKET SIZE ESTIMATION
  • FIGURE 5: MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 6: SYNTHETIC STEM CELLS MARKET, BY APPLICATION (2023)
  • FIGURE 7: GEOGRAPHICAL SNAPSHOT OF THE SYNTHETIC STEM CELLS MARKET (2023)
  • FIGURE 8: ETHICAL CONCERNS, RISKS ASSOCIATED WITH NATURAL STEM CELLS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 9: CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE SYNTHETIC STEM CELLS MARKET
  • FIGURE 10: NORTH AMERICA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 11: STEM CELL RESEARCH FUNDING (USD MILLION)
  • FIGURE 12: STEM CELL CLINICAL TRIALS
  • FIGURE 13: CARDIOVASCULAR DISEASE: CLINICAL TRIALS
  • FIGURE 14: NEUROLOGICAL DISORDERS: CLINICAL TRIALS
  • FIGURE 15: OTHER APPLICATIONS: CLINICAL TRIALS
  • FIGURE 16: GEOGRAPHIC SNAPSHOT: NORTH AMERICAN SYNTHETIC STEM CELLS MARKET
  • FIGURE 17: EUROPEAN COUNTRIES: STEM CELL CLINICAL TRIALS
目次
Product Code: BT 6778

"Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market."

The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5% during the forecast period. The synthetic stem cells market is driven by various factors such as ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. However, the unclear and unstructured regulations on the use of synthetic stem cells can hinder the growth of the market.

"The neurological disorders segment is expected to witness the highest CAGR during the forecast period."

The neurological disorders application is the faster-growing segment in the overall synthetic stem cells market. Based on application, the synthetic stem cells market is segmented into cardiovascular diseases, neurological disorders, and other diseases that include various cancers, wounds and injuries, musculoskeletal disorders, and blood disorders that require regenerative therapies.

"North America is expected to record the highest growth rate during the forecast period."

Countries in North America are constantly modernizing their healthcare infrastructure by investing in advanced therapies. The increasing prevalence of target diseases, focus on development of for regenerative medicines, fast adoption of advanced therapies, and regulatory support for stem cell therapies will result in the high rate of adoption of synthetic stem cell therapies in this region by 2023.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the synthetic stem cells market.

  • By Company Type: Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
  • By Designation: C-level Executives: 34%, Directors: 42%, and Others: 24%
  • By Region: North America: 32%, Europe: 30%, APAC: 24%, and RoW: 14%

The synthetic stem cells market comprises two major providers, namely, North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Research Coverage:

This market study covers the synthetic stem cells market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on application and region.

Key Benefits of Buying the Report:

The report will provide the market leaders/new entrants in this market with information on the closest approximations of the revenue of the overall synthetic stem cells market and its subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS SCOPE
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Ethical concerns regarding embryonic stem cells
      • 5.2.1.2. Risk of tumor formation and immune rejection of natural stem cells
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Unclear and unstructured regulations
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Costly storage and fragility of natural stem cells
      • 5.2.3.2. Potential application in major indications
      • 5.2.3.3. Increasing stem cell research funding
  • 5.3. MARKET IMPACT ANALYSIS

6. SYNTHETIC STEM CELLS MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. CARDIOVASCULAR DISEASES
  • 6.3. NEUROLOGICAL DISORDERS
  • 6.4. OTHER APPLICATIONS

7. SYNTHETIC STEM CELLS MARKET, BY REGION

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA
    • 7.2.1. US
    • 7.2.2. CANADA
  • 7.3. EUROPE
  • 7.4. ASIA PACIFIC
  • 7.5. REST OF THE WORLD (ROW)

8. UNIVERSITY PROFILES

  • 8.1. NORTH CAROLINA STATE UNIVERSITY
  • 8.2. ZHENGZHOU UNIVERSITY

9. APPENDIX

  • 9.1. INSIGHTS OF INDUSTRY EXPERTS
  • 9.2. DISCUSSION GUIDE
  • 9.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 9.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 9.6. AUTHORS DETAILS
Back to Top